Skip to content

13F-HR filed by HOPLITE CAPITAL MANAGEMENT, L.P.

HOPLITE CAPITAL MANAGEMENT, L.P. filed this 13F-HR for the quarter ended 2015-03-31, filed 2015-05-15, with 28 holding rows worth $3,241,237,000.

Accession
0000919574-15-004336
Filed
2015-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2015

A holdings report, 28 entries on the cover page, a total value of $3,241,237,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,241,238,000 with VALUE read as thousands by filing date, 13F file number 028-10749. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ACTAVIS PLCG0083B108SHS874,730$260,337,000thousands by filing date
SEALED AIR CORP NEW81211K100COM5,041,028$229,669,000thousands by filing date
VALEANT PHARMACEUTICALS INTL91911K102COM962,721$191,216,000thousands by filing date
GRACE W R & CO DEL NEW COM38388F108Stock1,888,524$186,718,000thousands by filing date
BAIDU INC SPON ADR REP A056752108ADR863,786$180,013,000thousands by filing date
Broadcom IncY0486S104Common1,287,168$163,445,000thousands by filing date
WALGREENS BOOTS ALLIANCE INC931427108COM1,911,825$161,893,000thousands by filing date
GRAPHIC PACKAGING HLDG CO COM388689101Stock10,230,286$148,748,000thousands by filing date
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock840,966$145,311,000thousands by filing date
CHARTER COMMUNICATION - A16117M305COM694,795$134,172,000thousands by filing date
CONSTELLATION BRANDS INC CL A21036P108Stock1,127,802$131,062,000thousands by filing date
COCA COLA ENTERPRISES INC NE19122T109COM2,657,874$117,478,000thousands by filing date
SINCLAIR BROADCAST GROUP INC829226109CL A3,476,121$109,185,000thousands by filing date
ENVISION HEALTHCARE HLDGS IN29413U103COM2,616,849$100,356,000thousands by filing date
Micron Technology,Inc.595112103COM3,694,973$100,245,000thousands by filing date
Abbott Laboratories002824100COM2,017,245$93,459,000thousands by filing date
CTRIP COM INTL LTD22943F100AMERICAN DEP SHS1,593,699$93,423,000thousands by filing date
AIR PRODS & CHEMS INC009158106COM588,180$88,980,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR1,343,431$83,696,000thousands by filing date
EBAY INC. COM278642103Stock1,422,304$82,038,000thousands by filing date
McDonalds Corporation580135101COM834,103$81,275,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM635,205$74,935,000thousands by filing date
CENCORA INC COM03073E105Stock650,661$73,961,000thousands by filing date
SALIX PHARMACEUTICALS INC795435106COM359,850$62,186,000thousands by filing date
Waste Connections941053100COM1,061,167$51,085,000thousands by filing date
AbbVie,Inc.00287Y109COM836,608$48,975,000thousands by filing date
MYLAN NVN59465109SHS EURO790,936$46,942,000thousands by filing date
BERKSHIRE HATHAWAY INC DEL084670108CL A2$435,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-15-004336this filing2015-05-15acceptance time not in the bulk data set